As part of the HAL-OX research network, scientists at Martin Luther University Halle-Wittenberg have been funded to work on collaborative projects with research groups in Oxford. It is planned that these scientists will conduct part of their research in guest laboratories in Oxford.
Project title: Identification and characterization of C5 high-grade serous ovarian cancers using novel approaches
Project manager: Dr. Nadine Bley, Medizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg, Institut für Molekulare Medizin, Molekulare Zellbiologie
Collaboration: Prof. Ahmed Ashour Ahmed, University of Oxford, Weatherall Institute of Molecular Medicine, Nuffield Department of Women's & Reproductive Health
Funding period: 01.03.2019 - 31.01.2022
Project title: Molecular and ultrastructural analysis of the cancer cell survival-promoting signaling complex p35Gab1 - Grb2 - p85 PI3K
Project manager: Prof. Stephan Feller, Medizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg, Institut für Molekulare Medizin, Tumorbiologie
Collaboration: Prof. Chas Bountra, University of Oxford, Structural Genomics Consortium
Funding period: 15.10.2020 - 31.12.2022
Project title: New anti-cancer drugs at the horizon: Cysteine-guided targeting of oncofetal RNA-binding proteins
Project manager: Prof. Stefan Hüttelmaier, Medizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg, Institut für Molekulare Medizin, Molekulare Zellbiologie
Collaboration: Prof. Alfredo Castello, University of Oxford, Department of Biochemistry
Funding period: 01.01.2021 - 31.12.2021
Project title: Deciphering the therapeutic potential of human multinucleated giant cells for adipose tissue inflammation and type 2 diabetes
Project manager: Prof. Martin Gericke, Medizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg, Institut für Anatomie und Zellbiologie
Collaboration: Prof. Siamon Gordon, University of Oxford, Sir William Dunn School of Pathology
Funding period: 01.02.2021 - 31.12.2022
Project title: Epidemiology of infectious diseases and cancer in sub Saharan Africa
Project manager: Dr. Eva Kantelhardt, Medizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg, Institut für Medizinische Epidemiologie, Biometrie und Informatik, Global Health
Collaboration: Dr. Donald Maxwell Parkin, University of Oxford, Nuffield Department of Population Health, Clinical Trial Services Unit
Funding period: 01.02.2021 - 31.12.2022
Project title: Interplay between ER stress and DNA damage response in mouse models of inflammation-induced pancreatic cancer
Project manager: Prof. Jonas Rosendahl, Universitätsklinikum Halle (Saale), Department für Innere Medizin, Universitätsklinik und Poliklinik für Innere Medizin I
Collaboration: Dr. Bart Cornelissen, University of Oxford, Oxford Institute for Radiation Oncology, Radiopharmaceuticals and Molecular Imaging Research Group
Funding period: 01.01.2022 - 31.12.2022
Project title: Epidemiology and Health Service Research
Project manager: Dr. Eva Kantelhardt, Medizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg, Institut für Medizinische Epidemiologie, Biometrie und Informatik, Global Health
Collaboration: Dr. Donald Maxwell Parkin, University of Oxford, Nuffield Department of Population Health, Clinical Trial Services Unit
Funding period: 01.06.2022 - 31.12.2022
HAL-OX also funds travel support and student assistance for laboratory projects that promote collaborative biomedical research between Martin Luther University Halle-Wittenberg (MLU) and research institutes in Oxford.
For example, Dr. Heidi Olzscha, formerly a member of the Medical Sciences Division in Oxford (Nicholas La Thangue group), was supported with travel grants on several occasions and finally decided to join the Institute of Physiological Chemistry at the Medical Faculty of Martin Luther University Halle-Wittenberg as a senior researcher.
Other collaborations funded include Dr. Donald Maxwell Parkin and Biying Liu (African Cancer Registry Programme, Oxford) as well as Dr. Eva Kantelhardt (Medizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg, Institut für Medizinische Epidemiologie, Biometrie und Informatik, Global Health).
